Pharmacological modification of the epithelial permeability by benzalkonium chloride in UVA/Riboflavin corneal collagen cross-linking

Current Eye Research

Volumn 35, Issue 8, 2010, Pages 715-721

  Kissner, Anja ^a   Spoerl, Eberhard ^a   Jung, Roland ^a   Spekl, Kathrin ^a   Pillunat, Lutz E ^a   Raiskup, Frederik ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Benzalkonium chloride; Cross linking; Intact epithelium; Keratoconus; Riboflavin and UVA

Indexed keywords

BENZALKONIUM CHLORIDE; COLLAGEN; RIBOFLAVIN; BENZALKONIUM; CROSS LINKING REAGENT; PHOTOSENSITIZING AGENT; PRESERVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; CORNEA EDEMA; CORNEA EPITHELIUM; CROSS LINKING; DEBRIDEMENT; DRUG ABSORPTION; FEMALE; MEMBRANE PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; RABBIT; RADIATION ABSORPTION; STRESS STRAIN RELATIONSHIP; ULTRAVIOLET A RADIATION; ABSORPTION; ANIMAL; CORNEA STROMA; DRUG EFFECTS; EPITHELIUM CELL; METABOLISM; PERMEABILITY; ULTRAVIOLET RADIATION;

ABSORPTION; ANIMALS; BENZALKONIUM COMPOUNDS; COLLAGEN; CORNEAL STROMA; CROSS-LINKING REAGENTS; DEBRIDEMENT; EPITHELIAL CELLS; EPITHELIUM, CORNEAL; PERMEABILITY; PHOTOSENSITIZING AGENTS; PRESERVATIVES, PHARMACEUTICAL; RABBITS; RIBOFLAVIN; ULTRAVIOLET RAYS;

EID: 77955149133     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2010.481068     Document Type: Article

References (42)

1. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135:620-624.
2. Raiskup-Wolf F, Hoyer A, Spoerl E, et al. Collagen crosslinking with riboflavin and ultraviolet-A light in keratoconus: Long term results. J Cataract Refract Surg. 2008;34:796-801.
3. Kohlhaas M, Spoerl E, Sandner D, et al. A new treatment of keratectasia after LASIK by using collagen with riboflavin/ UVA light cross-linking. Klin Monatsbl Augenheilkd. 2005;222:430-436.
4. Spoerl E, Huhle M, Kasper M, et al. Increased rigidity of the cornea caused by intrastromal cross-linking. Der Ophthalmologe. 1997;94:902-906.
5. Seiler T, Spoerl E, Huhle M, et al. Conservative therapy of keratoconus by enhancement of collagen cross-links. IOVS. 1996;37:S1017 ARVO Abstract #4671.
6. Spoerl E, Schreiber J, Hellmund K, et al. Studies on the stabilization of the cornea in rabbits. Ophthalmologe. 2000;97:203-206.
7. Schreiber J. Verfestigung der Hornhaut durch UVA 365 nm und Riboflavin oder durch Glutaraldehyd. Dissertation, TU Dresden, 2003.
8. Wollensak G, Spoerl E, Seiler T. Stress-strain measurements of human and porcine corneas after riboflavin-ultraviolet- A-induced cross-linking. J Cataract Refract Surg. 2003;29: 1780-1785.
9. Wollensak G. Crosslinking treatment of progressive keratoconus: New hope. Curr Opin Ophthalmol. 2006;17:356-360.
10. Mazzotta C, Balestrazzi A, Traversi C, et al. Treatment of progressive keratoconus by riboflavin-UVA-induced crosslinking of corneal collagen. Ultrastructural analysis by Heidelberg retinal tomograph II in vivo confocal microscopy in humans. Cornea. 2007;26:390-397.
11. Wollensak G, Spoerl E, Wilsch M, et al. Endothelial cell damage after riboflavin-ultraviolet-A treatment in the rabbit. J Cataract Refract Surg. 2003;29:1786-1790.
12. Spoerl E, Mrochen M, Sliney D, et al. Safety of UVA-riboflavin cross-linking of the cornea. Cornea. 2007;26:385-389.
13. Schilde T, Kohlhaas M, Spoerl E, et al. Studies on the stabilization of the cornea in rabbits. Ophthalmologe. 2008;105:165-169.
14. Spoerl E, Raiskup-Wolf F, Pillunat LE. Biophysical principles of collagen cross-linking. Klin Monatsbl Augenheilkd. 2008;225:131-137.
15. Kohlhaas M, Spoerl E, Schilde T, et al. Biomechanical evidence of the distribution of crosslinks in riboflavin/ UVA-light treated cornea. J Cataract Refract Surg. 2006;32:279-283.
16. Baiocchi S, Mazzotta C, Cerretani D, et al. Corneal crosslinking: Riboflavin concentration in corneal stroma exposed with and without epithelium. J Cataract Refract Surg. 2009;35:893-899.
17. Hayes S, OBart DP, Lamdin LS, et al. Effect of complete epithelial debridement before riboflavin-ultraviolet-A corneal collagen crosslinking therapy. J Cataract Refract Surg. 2008;34:657-661.
18. Hayes S, OBrart DP. Reply: Effect of epithelial debridement in corneal collagen crosslinking therapy in porcine and human eyes. J Cataract Refract Surg. 2008;34:1816.
19. Yuen L, Chan C, Boxer Wachler BS. Effect of epithelial debridement in corneal collagen crosslinking therapy in porcine and human eyes. J Cataract Refract Surg. 2008;34: 1815-1816.
20. Hayes S, Boote C, Lewis J, et al. Comparative study of fibrillar collagen arrangement in the corneas of primates and other mammals. Anat Rec (Hoboken). 2007;290:1542-1550.
21. Walsh JE, Bergmanson JP, Koehler LV, et al. Fibre optic spectrophotometry for the in vitro evaluation of ultraviolet radiation (UVR) spectral transmittance of rabbit corneas. Physiol Meas. 2008;29:375-388.
22. Li HF, Petroll WM, Møller-Pedersen T, et al. Epithelial and corneal thickness measurements by in vivo confocal microscopy through focusing (CMTF). Curr Eye Res. 1997;16: 214-221.
23. Reichel S. Entwicklung porciner und humaner organotypischer cornealer Zellkulturmodelle für in vitro Permeationsuntersuchungen. Dissertation, TU Braunschweig, 2003.
24. Prausnitz MR, Noonan JS. Permeability of cornea, sclera and conjunctiva: A literature analysis for drug delivery to the eye. J Pharm Sci. 1998;87:1479-1488.
25. Malhotra M, Majumdar DK. Permeation through cornea. Indian J Exp Biol. 2001;39:11-24.
26. McCarey B, Edelhauser H. In vivo corneal epithelial permeability following treatment with prostaglandin analogs [correction of analoges] with or without benzalkonium chloride. J Ocul Pharmacol Ther. 2007;23:445-451.
27. Liang H, Baudouin C, Pauly A, et al. Conjunctival and corneal reactions in rabbits following short and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride. Br J Ophthalmol. 2008;92:1275-1282.
28. Cha SH, Lee JS, Oum BS, et al. Corneal epithelial cellular dysfunction from benzalkonium chloride (BAC) in vitro. Clin Experiment Ophthalmol. 2004;32:180-184.
29. Kaur IP, Smitha R. Penetration enhancers and ocular bioadhesives: Two new avenues for ophthalmic drug delivery. Drug Dev Ind Pharm. 2002;28:353-369.
30. Van der Bijl P, van Eyk AD, Meyer D. Effects of three penetration enhancers on transcorneal permeation of cyclosporine. Cornea. 2001;20:505-508.
31. Ramselaar JAM, Boot JP, van Haeringen NJ, et al. Corneal epithelial permeability after instillation of ophthalmic solutions containing local anaesthetics and preservatives. Curr Eye Res. 1988;7:947-950.
32. Boxer Wachler B. Corneal collagen crosslinking with riboflavin. Cataract & Refract Surg Today. 2005;1:73-74.
33. Chan CCK, Sharma M, Boxer Wachler BS. Effect of inferiorsegment Intacs with and without C3-R on keratoconus. J Cataract Refract Surg. 2007;33:75-80.
34. Pinelli R. Corneal cross-linking with riboflavin: Entering a new era in ophthalmology. Ophthalmology Times Europe. 2006;2:36-38.
35. Wollensak G, Iomdina E. Biomechanical and histological changes after corneal crosslinking with and without epithelial debridement. J Cataract Refract Surg. 2009;35: 540-546.
36. Pinelli R, Mometto C. Corneal abrasion for CCL contra. 3rd International Congress of Corneal Cross Linking, Zurich, Switzerland, 7-8 December 2007.
37. Wollensak G, Iomdina E. Long-term biomechanical properties of rabbit cornea after photodynamic collagen crosslinking. Acta Ophthalmol. 2009;87:48-51.
38. Spoerl E, Wollensak G, Seiler T. Increased resistance of crosslinked cornea against enzymatic digestion. Curr Eye Res. 2004;29:35-40.
39. Maurice D, Perlman M. Permanent destruction of the corneal endothelium in rabbits. Invest Ophthalmol Vis Sci. 1977;16:646-649.
40. Olsen EG, Davanger M.The healing of rabbit corneal endothelium. Corneal riboflavin concentration: HLPC with and without epithelium. Acta Ophthalmol. 1984;62: 796-807.
41. Hughes EH, Pretorius M, Eleftheriadis H, et al. Longterm recovery of the human corneal endothelium after toxic injury by benzalkonium chloride. Br J Ophthalmol. 2007;91:1460-1463.
42. Ayaki M, Yaguchi S, Iwasawa A, et al. Cytotoxicity of ophthalmic solutions with and without preservatives to human corneal endothelial cells, epithelial cells and conjunctival epithelial cells. Clin Experiment Ophthalmol. 2008;36: 553-559.